Protara Therapeutics Inc Cash Flow-to-Debt Ratio
Protara Therapeutics Inc cash flow-to-debt ratio. Protara Therapeutics Inc (TARA) has a Cash Flow-to-Debt Ratio of -0.95x as of June 2026, meaning its operating cash flow of $-14.06 Million could theoretically repay -1% of its total liabilities ($14.78 Million) in one year. Check TARA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Protara Therapeutics Inc (2012–2025)
Cash flow-to-debt ratio of Protara Therapeutics Inc from 2012 to 2025. Historical debt coverage capacity for Protara Therapeutics Inc across 14 annual periods. Check cash flow reinvestment rate of Protara Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Protara Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Protara Therapeutics Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Protara Therapeutics Inc. For the full cash flow conversion analysis, see Protara Therapeutics Inc (TARA) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.32x | $-56.37 Million | $13.06 Million | ▼ -72.6% |
| 2024 | -2.50x | $-35.81 Million | $14.32 Million | ▲ +29.2% |
| 2023 | -3.53x | $-37.56 Million | $10.63 Million | ▼ -49.6% |
| 2022 | -2.36x | $-26.46 Million | $11.21 Million | ▲ +26.9% |
| 2021 | -3.23x | $-34.50 Million | $10.68 Million | ▲ +46.0% |
| 2020 | -5.98x | $-23.41 Million | $3.91 Million | ▲ +77.7% |
| 2019 | -26.84x | $-15.65 Million | $583.00K | ▼ -255.5% |
| 2018 | -7.55x | $-23.23 Million | $3.08 Million | ▼ -212.0% |
| 2017 | -2.42x | $-22.35 Million | $9.24 Million | ▲ +48.1% |
| 2016 | -4.66x | $-23.69 Million | $5.08 Million | ▼ -9.7% |
| 2015 | -4.25x | $-17.57 Million | $4.13 Million | ▲ +0.5% |
| 2014 | -4.27x | $-9.99 Million | $2.34 Million | ▼ -522.7% |
| 2013 | -0.69x | $-6.70 Million | $9.77 Million | ▲ +65.4% |
| 2012 | -1.98x | $-8.23 Million | $4.15 Million | — |